From Physician to CEO: Leadership Insight for Success Tuesday, February 9, 2016 Belén Garijo is a Member of the Executive Board of Merck KGaA, Darmstadt, Germany, since January 2015. She is responsible for the Healthcare business sector, comprising the businesses of Biopharma, Consumer Health, Allergopharma and Biosimilars. Since 2013 she also acts as President and CEO of Biopharma, where she started in 2011 as Chief Operating Officer. Before joining Merck KGaA, Darmstadt, Germany, Belén Garijo was employed by Sanofi-Aventis as Senior Vice … Continue reading “Belén Garijo, Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO Healthcare”
Leadership in Exporting the First Amendment Thursday, November 19, 2015 David Ensor is a Fall Term Fellow at the Shorenstein Center in the Harvard Kennedy School, writing about U.S. international broadcasting and digital media. In May, he completed four years serving as Director of the Voice of America in Washington, DC. VOA is a U.S. funded, editorially independent media organization, which reaches over 170 million people a week in 45 languages through television, radio, internet and social media. Ensor also … Continue reading “David Ensor, Former Director, Voice of America”
Leadership in Innovation Wednesday, September 9, 2016 Gerald Chan is the co-founder of Morningside, a private investment group with venture, private equity and property investments. In the life science sector, Morningside focuses on start-up biotechnology companies founded on novel scientific discoveries. Gerald serves on the boards of Advanced Cell Diagnostics, Stealth BioTherapeutics, Synchroneuron, Apellis, Atea, Kezar, Nucana, Aduro, VTI and Matrivax. Gerald is a member of the Global Advisory Council of the International Society for Stem Cell Research, the Dean’s Board of Advisors … Continue reading “Gerald Chan, Chairman and CEO, Morningside Group”
Leadership Along the Path We Have Chosen Tuesday, March 31, 2015 John Lechleiter has served as president and chief executive officer of Eli Lilly and Company since, and became chairman of the board of directors in 2009. John joined Lilly in 1979 as a senior organic chemist in process research and development and became head of that department. He began serving as director of pharmaceutical product development for the Lilly Research Centre Limited in Windlesham, England, and later held roles … Continue reading “John Lechleiter, Chairman, President and Chief Executive Officer, Eli Lilly and Company”
Gabriel Jaramillo, who lead the broad transformation of The Global Fund To Fight AIDS, Tuberculosis and Malaria, discusses critical aspects of organizational change from his expertise in banking and how he transferred those skills to global health. This session is entitled “If It Works – Fix It: Leading Transformation at The Global Fund.”
Bill Strickland spoke on The Art of Leadership, discussing how his career evolved into starting Manchester Bidwell to educate inner city youth in Pittsburgh. He also discussed lessons he has learned in how to communicate with a broad range of people, and the importance of creating a positive environment to support at-risk young people.
Mr. Alexander discussed leadership in finding a common ground, common language, and common thinking as he transitioned from the world of business to the world of public health.
Paradigm of Leadership: A Women’s View Dr. Swati Piramal (MPH ’92) is the Director of Piramal Healthcare, a leading drug discovery company which aims to bring affordable medicines to reduce the burden of disease globally. Dr. Piramal leads a team of scientists in cancer, diabetes, inflammation and infectious disease research. As Director of the Piramal Foundation, which is engaged in inter-disciplinary and field based education, she helps promote health in rural India with HMRI—a mobile health service; women’s empowerment projects; … Continue reading “Swati Piramal, Director of Piramal Healthcare”
Crises, Crossroads, and Credibility Julie Gerberding is president of Merck Vaccines. She is responsible for the commercialization of the current portfolio of vaccines, planning for the introduction of vaccines from the company’s vaccine pipeline, and accelerating Merck’s ongoing efforts to broaden access to its vaccines in the developing world. Before joining Merck, Dr. Gerberding led the Centers for Disease Control and Prevention (CDC) as director from 2002 to 2009. In this position, she was responsible for coordinating more than 40 … Continue reading “Julie Gerberding, President, Merck Vaccines”